Recently, studies have reported that new parameters of inflammation, the peripheral blood albumin to globulin ratio (AGR) and albumin to fibrinogen ratio (AFR), can not only reflect the patient's nutrition, blood coagulation, and inflammation status simultaneously but also have a stronger power to improve the prognostic value of patients with lung cancer, gastric cancer and other tumors 9, 10. The gene discussed is ALB; the disease is lung carcinoma.